Combining Celecoxib and Plumbagin reduces the proliferation of melanoma cells and inhibits COX-2 and STAT3-mediated tumor vascular development, thereby inducing apoptosis in human fibroblast FF2441 cells (Gowda et al., 2017). This evidence concerns the gene PTGS2 and melanoma.